Pure Global

Comparator study in children investigating whole body exposure to Advair Inhalation alone or via the Aerochamber Plus Spacer or via Advair Diskus. - Trial 2015-004866-27

Access comprehensive clinical trial information for 2015-004866-27 through Pure Global AI's free database. This phase not specified trial is sponsored by GlaxoSmithKline Research & Development and is currently status unknown. The study focuses on Asthma.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
2015-004866-27
Trial Details
EU Clinical Trials Register โ€ข 2015-004866-27
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Comparator study in children investigating whole body exposure to Advair Inhalation alone or via the Aerochamber Plus Spacer or via Advair Diskus.

Study Focus

Asthma

Sponsor & Location

GlaxoSmithKline Research & Development

GlaxoSmithKline

Timeline & Enrollment

N/A

N/A

N/A

Primary Outcome

Serum cortisol weighted mean(0-12h) and Cmin (0-12h) (FP PD)

ICD-10 Classifications

Asthma
Asthma, unspecified
Nonallergic asthma
Mixed asthma
Predominantly allergic asthma

Data Source

EU Clinical Trials Register

2015-004866-27

Non-Device Trial